Activated macrophage membrane-coated nanoparticles relieve osteoarthritis-induced synovitis and joint damage

Osteoarthritis (OA) is a common joint condition that is a leading cause of disability worldwide. There are currently no disease-modifying treatments for osteoarthritis, which is associated with multiple kinds of inflammatory cytokines produced by M1 macrophages in the synovium of the joint. Despite...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomaterials 2023-04, Vol.295, p.122036-122036, Article 122036
Hauptverfasser:	Zhou, Kai, Yang, Chengli, Shi, Kun, Liu, Yue, Hu, Danrong, He, Xinlong, Yang, Yun, Chu, Bingyang, Peng, Jinrong, Zhou, Zongke, Qian, Zhiyong
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - pharmacology Cartilage damage Cytokines Humans Inflammation Inflammatory cytokine Macrophage Macrophages Nanoparticles - therapeutic use Osteoarthritis - drug therapy Synovial Membrane Synoviocyte Synovitis Synovitis - complications Synovitis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!